News
Sanofi and GSK to provide COVID-19 vaccine doses to COVAX Facility
Sanofi and GlaxoSmithKline have signed a statement of intent with Gavi to provide 200 million doses of their COVID-19 vaccine available to the COVAX Facility.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Sanofi and GlaxoSmithKline have signed a statement of intent with Gavi to provide 200 million doses of their COVID-19 vaccine available to the COVAX Facility.